We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01137695
Recruitment Status : Unknown
Verified October 2011 by Cheryl Rosenfeld, DO, North Jersey Endocrine Consultants, LLC.
Recruitment status was:  Active, not recruiting
First Posted : June 4, 2010
Last Update Posted : October 14, 2011
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2012
  Estimated Study Completion Date : April 2012